Neurological intensive care admissions: identifying candidates for intermediate care and the services they receive.
OBJECTIVE
The high cost and scarcity of intensive care unit (ICU) beds has resulted in a need for improved utilization. This study describes the characteristics of patients who are admitted to the ICU for neurosurgical and neurological care, identifies patients who might receive all or most of their care in an intermediate care unit, and describes the services the patients would receive in an intermediate care unit.


METHODS
We describe patients who received neurological care and who were part of a prospective study of 17,440 patients admitted to 42 ICUs at 40 United States hospitals. We identified patients who received only monitoring during ICU Day 1 and then used a previously validated equation to distinguish which patients were at low risk (< 10%) for subsequent active life-supporting therapy. We also describe the services these patients received during their ICU stay.


RESULTS
Among 3000 patients admitted to the ICU for neurological care, 1350 received active therapy and 1650 (55%) underwent monitoring and received concentrated nursing care on ICU Day 1. After excluding those patients who received active therapy at admission, 1288 (78%) of the 1650 patients who underwent monitoring at admission were at low risk (< 10%) for subsequent active therapy; 95.8% received no active therapy. These patients who were at low risk for subsequent active therapy were significantly (P < 0.001) more often admitted postoperatively, were younger and less severely ill, and had lower ICU and hospital mortality rates (0.9 and 3.9%, respectively) than patients who received active treatment at admission.


CONCLUSIONS
Patients receiving neurological care at an ICU who receive only monitoring during their 1st ICU day and have a less than 10% predicted risk of active treatment can be safely transferred to an intermediate care unit. Some of these patients may not require ICU admission. We suggest guidelines for equipping and staffing neurological intermediate care units based on the type and amount of therapy received by these patients.
Zimmerman
J E
JE
Department of Anesthesiology, George Washington University Medical Center, Washington, District of Columbia, USA.
Junker
C D
CD
Becker
R B
RB
Draper
E A
EA
Wagner
D P
DP
Knaus
W A
WA
D000328:Adult; D000368:Aged; D003422:Critical Care; D005260:Female; D006801:Humans; D008875:Middle Aged; D008991:Monitoring, Physiologic; D009422:Nervous System Diseases / Q000628:therapy*; D009732:Nursing Care; D010343:Patient Admission; D011446:Prospective Studies; D016896:Treatment Outcome; D014218:Triage